-
OncXerna Therapeutics Announces New Biomarker Data from Retrospective Analysis of Results from Phase 1b Ovarian Cancer Trial of Navicixizumab Plus Paclitaxel at the ESGO 2021 Congress
23 Oct 2021 13:49 GMT
… (“OncXerna”), a precision medicine company using an innovative RNA … cancer (PROC). Pre-treatment biopsies were analyzed using … bevacizumab) in a Phase 1b clinical trial. The U.S. Food and Drug … with an innovative precision medicine platform, the Xerna platform …
-
Ovarian Cancer Drugs Global Market To Grow At Rate Of 19% Through 2025
22 Oct 2021 09:13 GMT
… treat complex medical conditions. The pharmaceutical companies in the ovarian cancer drugs market … blockbuster tranquilize Avastin (bevacizumab), is a combination drug approved by FDA, with ingredients …
-
Avastin (Bevacizumab) Biosimilars Developer Landscape and Clinical Research Report 2021 - ResearchAndMarkets.com
20 Oct 2021 11:12 GMT
… products of the blockbuster biologic drug, Avastin, which are either … executive summary of the contemporary bevacizumab biosimilars market, featuring details, …
Shanghai Henlius biotech
Simcere
SinoCellTech
Sydlabs
TheraMabs
TL Pharmaceuticals
TOT Biopharm …
-
Head & Neck Cancer Drugs Market Rising Advancement in Screening & Diagnosis Procedures Drive the Growth
18 Oct 2021 06:08 GMT
… pipeline drugs such as Ipilimumab, Atezolizumab, Avelumab, Durvalumab, Erlotinib, Afatinib, Bevacizumab, and … , Bristol-Myers Squibb Company, Fortress Biotech, Inc. (Checkpoint Therapeutics, Inc.), … .
Request for 14 days free trial: https://www. …
-
Innovent Announces ORIENT-31, a Phase 3 Study of Sintilimab in Patients with EGFR-Mutated Nonsquamous Non-Small Cell Lung Cancer with Prior EGFR-TKI Treatment, Has Met Primary Endpoint
18 Oct 2021 00:25 GMT
… registrational or pivotal clinical trials.
In China, sintilimab … ® (bevacizumab biosimilar injection) for the first-line treatment of … #39;s National Reimbursement Drug List (NRDL) in … high-quality innovative medicines for the treatment of cancer, autoimmune …
-
FDA Approves First-Line Pembrolizumab Plus Chemo for Cervical Cancer
13 Oct 2021 23:22 GMT
The US Food and Drug Administration (FDA) has approved the … trial, presented last month at the European Society for Medical … chemotherapy with or without bevacizumab led to significant … with standard chemotherapy and bevacizumab, at the investigator…
-
Increasing HIV In Women Is A Key Driver For The Cervical Cancer Drugs Market
13 Oct 2021 09:08 GMT
… tablets. These drugs ease the localized treatment of cervical … Pharmaceuticals for Human Use (ICH)'s Clinical Trials … Registry, 851B Gel is in trial phase. … Cancer, Adenocarcinoma), By Drug Type (Avastin, Bevacizumab, Bleomycin, Blenoxane), …
-
Glioblastoma Multiforme Treatment (GBM) Market (2021): Production Growth, Threats & Challenges, Forecast By 2021 To 2030
12 Oct 2021 19:52 GMT
… market. The Glioblastoma Multiforme Treatment (GBM) company segmentation provides …
Global Glioblastoma Treatment Market Revenue and Forecast, by Drugs
Bevacizumab (Avastin)
… insights, namely, Glioblastoma Multiforme Treatment (GBM) industry trends, growth …
-
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
12 Oct 2021 12:47 GMT
… treatment)
Bicycle Therapeutics plc (NASDAQ: BCYC)
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA)
Itamar Medical … non-opioid pain drug portfolio
Petros Pharmaceuticals, Inc. … In Biotech (Oct. 10-16): Avadel FDA Decision … formulation of bevacizumab for use in …
-
Just Nine Companies Govern 100% Of The Pegfilgrastim Biosimilars Market As Per The Business Research Company's Global Pegfilgrastim Biosimilars Market Report 2021
18 Oct 2021 15:30 GMT
… pharmaceutical and biotechnology company revealed that the US Food and Drug Administration (FDA … By Application (Chemotherapy Treatment, Transplantation), By … ), the originating medication, which was … , Trastuzumab, Adalimumab, Bevacizumab), COVID-19 Growth And …
About
© 1995-2021